Biotest GmbH & Co. KGaA

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 2
Amount won alone: €216,001 excl. VAT
Period: 3 September 2026 – 29 September 2026

Its main clients

AOK Baden-Württemberg · 1 contract
AOK Sachsen - Anhalt · 1 contract

Where and what

Supplies · 2

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
31 August 2028 re-tender around March 2028	Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Haemoctin SDH (B02BD02) und Haemonine (B02BD04) zur Behandlung der Hämophilie AOK Sachsen - Anhalt	Biotest GmbH & Co. KGaA 1 bid received	€1
31 August 2028 re-tender around March 2028	Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zu den Wirkstoffen Blutgerinnungsfaktor VIII (human) sowie Blutgerinnungsfaktor IX (human) AOK Baden-Württemberg framework agreement	Biotest GmbH & Co. KGaA 1 bid received	€216,000

Contracts won

Date	Contract	Buyer	Amount
29/09/2026	Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zu den Wirkstoffen Blutgerinnungsfaktor VIII (human) sowie Blutgerinnungsfaktor IX (human)	AOK Baden-Württemberg	€216,000
03/09/2026	Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Haemoctin SDH (B02BD02) und Haemonine (B02BD04) zur Behandlung der Hämophilie	AOK Sachsen - Anhalt	€1

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.